CVE-2012-1674

CVE-2012-1674 is a medium-severity vulnerability in Oracle Industry Applications with a CVSS 2.0 base score of 4.0. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low.

Key facts

Description

Unspecified vulnerability in the Siebel Clinical component in Oracle Industry Applications 7.7, 7.8, 8.0.0.x, 8.1.1.x, and 8.2.2.x allows remote authenticated users to affect integrity via unknown vectors related to Web UI, a different vulnerability than CVE-2012-0582.

Frequently asked questions

What is CVE-2012-1674?
Unspecified vulnerability in the Siebel Clinical component in Oracle Industry Applications 7.7, 7.8, 8.0.0.x, 8.1.1.x, and 8.2.2.x allows remote authenticated users to affect integrity via unknown vectors related to Web UI, a different vulnerability than CVE-2012-0582.
How severe is CVE-2012-1674?
CVE-2012-1674 has a CVSS 2.0 base score of 4.0, rated medium severity.
Is CVE-2012-1674 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (62nd percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2012-1674?
CVE-2012-1674 primarily affects Oracle Industry Applications. In total, 5 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.
How do I fix CVE-2012-1674?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
When was CVE-2012-1674 published?
CVE-2012-1674 was published on 2012-05-03 and last updated on 2026-06-16.

References

Affected products (5)

More vulnerabilities in Oracle Industry Applications

All CVEs affecting Oracle Industry Applications →